Axogen (AXGN) Return on Capital Employed Growth (3y) (2014 - 2026)
Axogen (AXGN) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -846.00 |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | -247.00 |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 1,318.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | - |
| 10 | Axogen | 2.10 Bn | 2.00 Bn | 46.19 Mn | 1,110.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,110.00 |
| Dec 31, 2025 | 1,329.00 |
| Sep 30, 2025 | 1,925.00 |
| Jun 30, 2025 | 1,901.00 |
| Mar 31, 2025 | 1,673.00 |
| Dec 31, 2024 | 1,179.00 |
| Sep 30, 2024 | 853.00 |
| Jun 30, 2024 | 343.00 |
| Mar 31, 2024 | 73.00 |
| Dec 31, 2023 | 28.00 |
| Mar 31, 2023 | 778.00 |
| Dec 31, 2022 | 622.00 |
| Sep 30, 2022 | 443.00 |
| Jun 30, 2022 | 203.00 |
| Mar 31, 2022 | 93.00 |
| Dec 31, 2021 | 10.00 |
| Sep 30, 2021 | -258.00 |
| Jun 30, 2021 | 253.00 |
| Mar 31, 2021 | 1,170.00 |
| Dec 31, 2020 | 833.00 |